Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial public offering in the United States, according to a regulatory filing.

The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, 2024, as the Federal Reserve announced its first interest-rate cut since ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

The company shipped some 750 vials of testosterone to customers who had instead ordered tirzepatide, the active ingredient in ...

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

Healthcare firms have done comparatively well in an otherwise subdued U.S. IPO market in 2024, which analysts touted as a comeback year for public offerings. The Richmond, California-based company ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...

Healthcare technology company ResMed 's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost ...

SOMAÍ Pharmaceuticals partners with Georgelle to offer Irish patients a broad range of cannabis-based medicines, expanding ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...